Michael L. Jackson
Impact in
- Modeling and Simulation top 0.2%
- COVID-19 epidemiological studies
- Health top 0.2%
- Vaccine Coverage and Hesitancy
Papers in
- Epidemiology 115
- Influenza Virus Research Studies 91
- Respiratory viral infections research 61
- Pneumonia and Respiratory Infections 34
-
- SARS-CoV-2 and COVID-19 Research 17
- Viral Infections and Outbreaks Research 8
- Co-authors
- Lisa A. Jackson (58 shared papers)Jennifer C. Nelson (12 shared papers)Kathleen M. Neuzil (4 shared papers)Noel S. Weiss (7 shared papers)Edward A. Belongia (46 shared papers)Brendan Flannery (46 shared papers)Manjusha Gaglani (45 shared papers)Richard K. Zimmerman (42 shared papers)
- Journals
- Vaccine (22 papers)Clinical Infectious Diseases (15 papers)Pharmacoepidemiology and Drug Safety (9 papers)Open Forum Infectious Diseases (8 papers)Influenza and Other Respiratory Viruses (7 papers)
- Partner nations
- United StatesKenyaUnited Kingdom
In The Last Decade
Michael L. Jackson
147 papers receiving 5.6k citations
Peers
Comparison fields: 5 of 160
- Modeling and Simulation 773
- Health 1.3k
- Epidemiology 4.1k
- Microbiology 497
- Infectious Diseases 1.3k
Countries citing papers authored by Michael L. Jackson
This map shows the geographic impact of Michael L. Jackson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael L. Jackson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael L. Jackson more than expected).
Fields of papers citing papers by Michael L. Jackson
This network shows the impact of papers produced by Michael L. Jackson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael L. Jackson. The network helps show where Michael L. Jackson may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael L. Jackson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 151 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 367 | |
| 2 | 2004 | 335 | |
| 3 | 2013 | 312 | |
| 4 | 2016 | 211 | |
| 5 | 2017 | 194 | |
| 6 | Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015. | 2015 | 154 |
| 7 | 2014 | 153 | |
| 8 | 2016 | 147 | |
| 9 | 2011 | 144 | |
| 10 | 2016 | 141 | |
| 11 | 2018 | 141 | |
| 12 | 2008 | 135 | |
| 13 | 2020 | 123 | |
| 14 | 2008 | 122 | |
| 15 | 2018 | 117 | |
| 16 | 2021 | 95 | |
| 17 | 2010 | 93 | |
| 18 | 2016 | 86 | |
| 19 | 2009 | 81 | |
| 20 | 2020 | 79 |
About Michael L. Jackson
Michael L. Jackson is a scholar working on Epidemiology, Infectious Diseases, Health, Modeling and Simulation and Microbiology, having authored 151 papers that have together received 5.8k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (91 papers), Respiratory viral infections research (61 papers), Pneumonia and Respiratory Infections (34 papers), Vaccine Coverage and Hesitancy (32 papers), COVID-19 epidemiological studies (30 papers), Bacterial Infections and Vaccines (19 papers), SARS-CoV-2 and COVID-19 Research (17 papers) and Viral Infections and Outbreaks Research (8 papers). The work is most often cited by research in Modeling and Simulation (773 citations), Health (1.3k citations), Epidemiology (4.1k citations), Microbiology (497 citations) and Infectious Diseases (1.3k citations). Michael L. Jackson has collaborated with scholars based in United States, Kenya and United Kingdom. Frequent co-authors include Lisa A. Jackson, Jennifer C. Nelson, Kathleen M. Neuzil, Noel S. Weiss, Edward A. Belongia, Brendan Flannery, Manjusha Gaglani, Richard K. Zimmerman, Alicia M. Fry and Huong Q. McLean. Their work appears in journals such as Vaccine, Clinical Infectious Diseases, Pharmacoepidemiology and Drug Safety, Open Forum Infectious Diseases and Influenza and Other Respiratory Viruses.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.